Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 28, 2016; 22(48): 10523-10531
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10523
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10523
Author (yr) | Number of patients | Sex (M:F) | Age (yr, average) | Race or nationality | Clinical symptoms | Therapeutic method | Survival time (mo, average) | Outcome |
Tsukamoto et al[4] (2007) | 1 | F | 82 | Japanese | No symptom | EMR | ND | ND |
Ueyama et al[5] (2010) | 10 | 6:4 | 65.5 (42-79) | Japanese: 10 | ND | EMR: 2 | 37.1 (10-70) | Alive, NED: 10 |
ESD: 5 | ||||||||
Operation: 3 | ||||||||
Fukatsu et al[6] (2011) | 1 | M | 56 | Japanese | No symptom | EAM | 12 | Alive, NED |
Terada et al[7] (2011) | 1 | M | 78 | Japanese | Abdominal pain (colon cancer) | No therapy (only biopsy) | 3 | Died (colon cancer) |
Park et al[8] (2012) | 3 | 3:0 | 65.3 (47-76) | Korean: 3 | ND | ESD: 1 | 24.3 (11-32) | Alive, NED: 3 |
Operation: 1 | ||||||||
Operation after ESD: 1 | ||||||||
Singhi et al[9] (2012) | 10 | 4:6 | 64.2 (44-79) | Hispanic: 4 | GERD: 10 | polypectomy: 10 | 15.4 (6-39) | Alive, NED: 8 |
Caucasian: 2 | Alive, persistence: 1 ND: 1 | |||||||
African American: 2 | ||||||||
Chinese: 1 | ||||||||
Unknown: 1 | ||||||||
Chen et al[10] (2012) | 1 | M | 79 | Caucasian | GERD | EMR | 2 | Alive, NED |
Esophageal stricture | ||||||||
Abe et al[11] (2013) | 1 | F | 71 | Japanese | No symptom | EMR | 12 | Alive, NED |
Ueyama et al[12] (2014) | 10 | 6:4 | 66.5 (55-78) | Japanese: 10 | ND | EMR: 2 | 13.2 (1-19) | Alive, NED: 10 |
ESD: 8 | ||||||||
Miyazawa et al[13] (2015) | 5 | 3:2 | 72.2 (67-78) | Japanese: 5 | No symptom: 5 | ESD: 4 | 19.4 (10-28) | Alive, NED: 5 |
Operation after ESD: 1 | ||||||||
Parikh et al[14] (2015) | 1 | M | 66 | Caucasian | Heartburn (GERD) | EMR | ND | Alive, NED |
Kato et al[15] (2015) | 1 | M | 80s | Japanese | ND | CLEAN-NET | 3 | Alive, NED |
Fujii et al[16] (2015) | 1 | F | 64 | Japanese | ND | ESD | ND | ND |
Author (yr) | Number of patients | Location (U:M:L) | Size (mm, average) | Macroscopic shape | Color tone | Vessel findings | NBI with magnification | |
MSP | MVP | |||||||
Tsukamoto et al[4] (2007) | 1 | U | 16 | Elevated | Normal | Vasodilation | ND | ND |
Ueyama et al[5] (2010) | 10 | 10:0:0 | 8.6 (4-20) | Elevated: 5 | ND | ND | ND | ND |
Depressed: 5 | ||||||||
Fukatsu et al[6] (2011) | 1 | U | 5 | Elevated | Yellowish | ND | ND | ND |
Terada et al[7] (2011) | 1 | U | 20 | Elevated | Reddish | Vasodilation | ND | ND |
Park et al[8] (2012) | 3 | 1:1:1 | 2.6 (1.2-3.6) | Elevated and depressed: 3 | ND | ND | ND | ND |
Singhi et al[9] (2012) | 10 | 10:0:0 | 4.3 (2-8) | Elevated: 10 | ND | ND | ND | ND |
Chen et al[10] (2012) | 1 | U | 12 | Elevated | Whitish | Vasodilation | ND | ND |
Abe et al[11] (2013) | 1 | U | ND | Elevated | Yellowish | ND | ND | ND |
Ueyama et al[12] (2014) | 10 | 6:4:0 | 9.3 (3-31) | Elevated: 6 | Whitish: 8 | Vasodilation: 5 | ND | ND |
Depressed: 3 | Reddish: 2 | Normal: 5 | ||||||
Miyazawa et al[13] (2015) | 5 | 5:0:0 | 7.8 (5-13) | Elevated: 4 | Whitish: 3 | Vasodilation: 5 | Regular: 3 | Regular: 3 |
Flat: 1 | Normal: 2 | Absent: 2 | Irregular: 2 | |||||
Parikh et al[14] (2015) | 1 | U | 7 | Elevated | Reddish | Vasodilation | ND | ND |
Kato et al[15] (2015) | 1 | U | 15 | Elevated | Whitish | Vasodilation | Regular | Regular |
Fujii et al[16] (2015) | 1 | U | < 10 | Depressed | Whitish | Vasodilation | Absent | Irregular |
Author (year) | Number of patients | Background mucosa | Depth (M:SM) (µm, average) | Lymphatic invasion (+:-) | Venous invasion (+:-) | MUC2 (+:-) | MUC5AC (+:-) | MUC6 (+:-) | CD10 (+:-) | Overexpression of p53 (+:-) | Ki-67 LI (%, average) |
Tsukamoto et al[4] (2007) | 1 | ND | M | (-) | (-) | ND | ND | (+) | ND | ND | 7.9 |
Ueyama et al[5] (2010) | 10 | Normal: 7 | 1:9 | 0:10 | 0:10 | 0:10 | 1:9 | 10:0 | 0:10 | 0:10 | 3.6 |
Metaplasia: 1 | 844 (150 to 4000) | ||||||||||
ND: 2 | |||||||||||
Fukatsu et al[6] (2011) | 1 | ND | SM, 100 | (-) | (-) | ND | (-) | (+) | ND | ND | ND |
Park et al[8] (2012) | 3 | Metaplasia: 2 | 1:2 | 0:3 | 0:3 | 0:3 | 3:0 | 3:0 | 0:3 | ND | ND |
Gastritis: 1 | |||||||||||
Singhi et al[9] (2012) | 10 | Normal: 7 | 10:0 | 0:10 | 0:10 | 0:3 | 0:10 | 10:0 | ND | 0:9 | 2.6 |
Gastritis: 3 | ND: 1 | (0.2-10) | |||||||||
Chen et al[10] (2012) | 1 | Normal | SM (Details unknown) | (-) | (-) | (-) | (-) | (-) | (-) | (-) | 3.8 |
Abe et al[11] (2013) | 1 | Normal | SM (Details unknown) | (-) | (-) | (-) | (-) | (-) | (-) | (-) | 1.9 |
Ueyama et al[12] (2014) | 10 | Normal: 9 | 5:5 | 1:9 | 0:10 | 0:10 | 4:6 | 10:0 | 2:8 | 0:10 | 8.6 (1-20) |
Gastritis: 1 | 360 (100 to 1200) | ||||||||||
Miyazawa et al[13] (2015) | 5 | Normal: 4 | 0:5 | 1:4 | 0:5 | 0:5 | 0:5 | 5:0 | ND | 0:5 | Very low: 5 (Details unknown) |
Gastritis: 1 | 620 (80 to 1230) | ||||||||||
Parikh et al[14] (2015) | 1 | ND | SM (Details unknown) | (-) | (-) | ND | ND | ND | ND | ND | ND |
Kato et al[15] (2015) | 1 | Normal | SM, 300 | (-) | (-) | ND | ND | (+) | ND | ND | ND |
Fujii et al[16] (2015) | 1 | Normal | SM, 300 | (-) | (-) | ND | (-) | (+) | ND | ND | ND |
- Citation: Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features. World J Gastroenterol 2016; 22(48): 10523-10531
- URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10523.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i48.10523